|
Volumn 8, Issue 8, 2012, Pages 419-421
|
Migraine: New US guidelines for preventive treatment of migraine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANTIMIGRAINE AGENT;
ATENOLOL;
BISOPROLOL;
CANDESARTAN;
CARBAMAZEPINE;
CLONIDINE;
CYPROHEPTADINE;
FENOPROFEN;
FLUNARIZINE;
GABAPENTIN;
GUANFACINE;
HISTAMINE;
IBUPROFEN;
KETOPROFEN;
LISINOPRIL;
MEFENAMIC ACID;
METOPROLOL;
NADOLOL;
NAPROXEN;
NEBIVOLOL;
PINDOLOL;
PLACEBO;
PROPRANOLOL;
TIMOLOL;
TOPIRAMATE;
VALPROATE SEMISODIUM;
VALPROIC ACID;
VENLAFAXINE;
AWARENESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
EVIDENCE BASED PRACTICE;
HUMAN;
MEDICAL SOCIETY;
MIGRAINE;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROPHYLAXIS;
REVIEW;
UNSPECIFIED SIDE EFFECT;
GUIDELINES AS TOPIC;
HUMANS;
MIGRAINE DISORDERS;
UNITED STATES;
|
EID: 84864991628
PISSN: 17594758
EISSN: 17594766
Source Type: Journal
DOI: 10.1038/nrneurol.2012.115 Document Type: Review |
Times cited : (4)
|
References (10)
|